Endo Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA, Inc. et al
| Endo Pharmaceuticals Inc. and Grunenthal GMBH |
| Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Barr Laboratories, Inc. |
| 1:2012cv08060 |
| November 5, 2012 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| XX Out of U.S. |
| Unassigned |
| Patent |
| 35 U.S.C. ยง 145 Patent Infringement |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
255
OMNIBUS OPINION: For the reasons set forth above, the court declines to alter the effective dates of Moving Defendants' ANDAs under 35 U.S.C. § 271(e)(4)(A) but enjoins Moving Defendants from making or selling their generic products prior to the expiration of the '122 and '216 patents. The court declines to enter a stay pending appeal and declines to schedule a damages trial. Finally, the court will file a corrected judgment under a separate docket number. This omni bus opinion resolves all open items for the following docket numbers: 12-cv-8060, 12-cv-8115, 12-cv-8317, 12-cv-8985, 13-cv-0435, 13-cv-0436, 13-cv-3288, 13-cv-4343, and 13-cv-8597. (As further set forth in this Opinion) (Signed by Judge Thomas P. Griesa on 4/29/2016) (kl)
|
|
Filing
148
OPINION: For the reasons given above, defendants' motions for summary judgment are granted with regard to United States Patent Number 8,114,383. Summary judgment is denied with regard to United States patent numbers 8,309,060 and 8,192,722. SO ORDERED. (Signed by Judge Thomas P. Griesa on 3/17/2015) (kl)
|
|
Filing
86
OPINION: For the reasons give, defendant's motion for leave to amend their answer and counterclaims is granted. This opinion resolves the item listed as document number 61 in this case. SO ORDERED. (See Order.) (Signed by Judge Thomas P. Griesa on 12/4/2014) (ajs)
|
|
Filing
77
OPINION: Dechert may participate in the inter parties review proceedings instituted by Amneal subject to two restrictions. First, Dechert may not amend, draft, or consult with Endo or Mayer Brown regarding the amendment of patent claims. Second, Dech ert may not share with Mayer Brown any information designated confidential under the Amneal protective order or any related protective order or share any information about defendants' ANDA products. (Signed by Judge Thomas P. Griesa on 8/13/2014) (ama)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
